Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2021 May 6;21:508. doi: 10.1186/s12885-021-08254-0

Geospatial analysis, web-based mapping and determinants of prostate cancer incidence in Georgia counties: evidence from the 2012–2016 SEER data

Justice Moses K Aheto 1,2,, Ovie A Utuama 2, Getachew A Dagne 2
PMCID: PMC8101113  PMID: 33957887

Abstract

Background

Prostate cancer (CaP) cases are high in the United States. According to the American Cancer Society, there are an estimated number of 174,650 CaP new cases in 2019. The estimated number of deaths from CaP in 2019 is 31,620, making CaP the second leading cause of cancer deaths among American men with lung cancer been the first. Our goal is to estimate and map prostate cancer relative risk, with the ultimate goal of identifying counties at higher risk where interventions and further research can be targeted.

Methods

The 2012–2016 Surveillance, Epidemiology, and End Results (SEER) Program data was used in this study. Analyses were conducted on 159 Georgia counties. The outcome variable is incident prostate cancer. We employed a Bayesian geospatial model to investigate both measured and unmeasured spatial risk factors for prostate cancer. We visualised the risk of prostate cancer by mapping the predicted relative risk and exceedance probabilities. We finally developed interactive web-based maps to guide optimal policy formulation and intervention strategies.

Results

Number of persons above age 65 years and below poverty, higher median family income, number of foreign born and unemployed were risk factors independently associated with prostate cancer risk in the non-spatial model. Except for the number of foreign born, all these risk factors were also significant in the spatial model with the same direction of effects. Substantial geographical variations in prostate cancer incidence were found in the study. The predicted mean relative risk was 1.20 with a range of 0.53 to 2.92. Individuals residing in Towns, Clay, Union, Putnam, Quitman, and Greene counties were at increased risk of prostate cancer incidence while those residing in Chattahoochee were at the lowest risk of prostate cancer incidence.

Conclusion

Our results can be used as an effective tool in the identification of counties that require targeted interventions and further research by program managers and policy makers as part of an overall strategy in reducing the prostate cancer burden in Georgia State and the United States as a whole.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12885-021-08254-0.

Keywords: Prostate cancer, Geospatial modelling, Mapping prostate cancer, Disease mapping, R-INLA, SEER program, Georgia, USA

Background

Prostate cancer is the leading diagnosis of malignancy and the second cause of mortality among American men, with an estimated national annual health care cost of $9.8 billion [1, 2]. The United States Cancer Statistics reported 192,443 new cases of prostate cancer in 2016, with an incidence rate of 101 per 100,000 men, and 30,370 prostate cancer deaths or 19 deaths per 100,000 during the same year [3]. Despite an overall decline in incidence across the United States since the early 1990s [4], there remain pockets of high prostate cancer burden.

In the United States, the state of Georgia has the second largest annual incidence rate of prostate cancer [3]. In 2016, there were 7160 reported new cases and 889 deaths in the state, with associated incidence and mortality rates of 133 and 23 per 100,000 men, respectively [3]. African American (AA) men not only have higher incidence of prostate cancer but also demonstrate 60% more mortality than white men, after controlling for incidence [5]. As 32% of Georgia consists of AA [6], it represents an unusual opportunity to investigate community factors associated with a high-risk population. Although a few studies have identified high prostate cancer incidence in the southwest of the state [7, 8], the sociodemographic characteristics of these regions are not well described.

For the purpose of planning for prostate cancer interventions with limited health resources, it is important to characterize and identify predictors of high prostate cancer burden at the community level. The present study, therefore, aims to 1) model and map Georgia county incidence of prostate cancer, 2) evaluate county sociodemographic factors associated with high incidence of prostate cancer.

Methods

Data source and study population

We used the Surveillance, Epidemiology, End Results (SEER) population-based cancer registry, which is publicly available data to investigate county-level distribution of prostate cancer cases in the state of Georgia. For this ecological study, only newly diagnosed cases 40 years and older from January 1, 2012 through December 31, 2016 were used for this study, because case reporting to SEER from the greater Georgia area started in 2010 and at the time of analysis SEER’s most current county attributes data spanned the 2012 to 2016 period. The greater Georgia area includes all counties in the state, except the 15 represented by the older Atlanta and Rural Georgia areas previously reported to SEER [9]. Therefore, since 2010 SEER captures cancer data from all 159 counties in Georgia. The SEER Georgia registry reports clinical, or preferentially pathologic diagnosis of cancer from eligible patient records in hospitals, laboratories and physician offices [10, 11]. Patients must be Georgia residents at the time of diagnosis, even though the address of residence is not reported in the registry. Only patients with an International Classification of Diseases for Oncology, third edition, (ICD-O-3) with topography code C61 and behaviour code 3 were included for analysis. SEER, being one of the oldest registries in the country, represents the gold standard in reporting standards and data quality, with completeness rates of more than 97% [1214].

SEER data are publicly available deidentified records of cancer cases. Permission was sought from and granted by SEER Program to access and use the data for this study. We did not attempt to identify, contact patients or link records to identifiable health information.

Outcome variable

The outcome variable is the number of incident prostate cancer cases per county. Detailed information is provided under the statistical analysis section.

Covariates

The covariates used in this study were county-level variables for the period 2012–2016 identified in the literature to be associated with the prostate cancer incidence [2, 1517]. These included percentage of blacks in the counties, number of persons above 65 years of age in the counties, number of persons having at least a bachelor’s degree in the counties, mean age at diagnosis, number of persons living below poverty in the counties, number of foreign born persons in the counties, percentage of the rural population in the counties, monthly median family income in the counties, and number of unemployed.

Statistical analysis

We employed a Bayesian geospatial model to investigate both measured and unmeasured spatial risk factors for prostate cancer among men residing in 159 counties in Georgia State.

Model formulation

We set Yi to be the observed counts of prostate cancer cases in county i and Ei as the expected number of prostate cancer cases in county i. We implemented Besag-York-Mollié (BYM) model [18] to analyse the data. We assumed that Yi are conditionally independently Poisson distributed, and modelled as:

Yi~PoissonEiθi,i=1,2,,n

where n is the number of counties (i.e n = 159) and θi is the relative risk in county i. We expressed the logarithm of θi as:

logθi=β0+dxiβ+ui+vi,

where β0 is the intercept parameter that represents the overall risk, d(.) is a vector of observed covariates, β is a vector of regression coefficients for the covariates, ui is a spatial structured effect component. We modelled the ui using conditional autoregressive (CAR) distribution given as: uiui~Nu¯δiσu2i, and vi is an unstructured spatial effect defined as vi=N0σv2.

The relative risk θi quantifies whether county i has higher (θi > 1) or lower (θi < 1) risk than the average risk in the reference population. We produced the probabilities of predicted relative risk being greater than a given threshold c (exceedance probabilities, i.e. P(θi > c)).

Finally, we visualised the risk of prostate cancer by mapping the predicted relative risk and exceedance probabilities. We developed interactive web-based maps to guide optimal policy formulation and intervention strategies targeted at improving the survival of prostate cancer patients and the overall health of men in Georgia.

Using the Bayesian framework, we implemented our Poisson model through recommended strategies (i.e. Integrated Nested Laplace Approximation (INLA) with Stochastic Partial Differential Equation (SPDE)) [19, 20]. We followed non-informative approach in choosing our priors due to lack of reliable prior information about all parameters, and thus used the default priors available in the R-INLA package. All the analyses were implemented in R-INLA package [21, 22]. We used 95% Bayesian Credible intervals to declare statistical significance.

Results

Sample characteristics

On average, 31.6% Georgia county residents were African American or black while the percentage of persons aged ≥65 years was 15.6%. The mean percentage of persons having at least bachelor’s degree in the counties was 17.5% while the overall percentages of persons below poverty and foreign born were 21.6 and 4.6% respectively, and with an average of 60.% rural population among all counties. Overall, the median annual family income was $51,116 and the mean percentage of unemployed was 9.1% (Table 1).

Table 1.

Georgia county characteristics and crude prostate cancer incident rates, 2012–2016

% 65+ yrs % black % bachelor’s degree % poverty % foreign born % rural population % unemployed annual family income mean annual cases male population incidence rate
median per county mean per 100,000 men
All 15.65 31.69 17.53 21.66 4.61 60.48 9.14 $51,116 40 29,743 158.83
Appling 15.52 0.44 11.92 20.64 4.38 71.44 8.46 $46,350 22 9159 240.20
Atkinson 11.47 42.42 6.68 27.56 13.06 100.00 5.91 $35,000 1 4240 23.58
Bacon 14.35 58.80 13.20 18.30 4.68 69.29 5.29 $46,060 5 5491 91.06
Baker 19.54 21.48 11.00 15.66 5.05 100.00 3.20 $52,280 3 1673 179.32
Baldwin 13.78 51.12 18.42 29.70 2.55 35.14 8.20 $50,230 26 22,683 114.62
Banks 16.24 32.81 10.99 15.52 4.85 93.83 7.66 $50,010 8 9298 86.04
Barrow 11.19 48.78 16.79 14.47 6.91 30.06 8.60 $58,020 42 34,208 122.78
Bartow 12.76 11.24 18.51 14.76 4.68 35.23 7.65 $57,670 59 49,433 119.35
Ben Hill . 0.21 6.06 . . 34.00 . . 12 8439 142.20
Berrien 16.11 55.09 12.27 25.58 3.13 76.14 10.43 $43,070 15 9501 157.88
Bibb 13.94 30.36 24.59 27.79 3.61 14.41 11.32 $50,130 115 73,286 156.92
Bleckley 16.92 59.22 17.72 23.02 1.35 51.59 6.58 $49,520 8 6217 128.68
Brantley 14.42 49.38 9.51 21.18 0.85 99.45 9.15 $43,880 8 9189 87.06
Brooks 18.34 8.11 12.44 24.71 3.45 71.04 17.67 $44,000 12 7901 151.88
Bryan 9.99 5.33 33.34 13.27 4.54 52.34 9.26 $76,470 16 14,852 107.73
Bulloch 10.19 46.74 28.25 31.55 3.47 48.28 9.72 $50,350 28 35,030 79.93
Burke 14.02 29.67 10.40 30.50 2.05 75.00 7.30 $39,800 9 11,186 80.46
Butts 14.45 37.61 10.20 20.53 2.99 77.94 8.35 $53,170 19 12,522 151.73
Calhoun 12.53 32.86 10.29 32.71 4.21 100.00 14.41 $33,330 8 3953 202.38
Camden 11.18 33.55 22.62 13.98 3.74 31.44 9.27 $60,560 35 25,569 136.88
Candler 16.47 55.10 14.23 29.72 4.94 66.97 7.09 $37,140 8 5437 147.14
Carroll 12.41 38.48 18.19 19.26 3.71 41.83 10.80 $55,020 53 53,793 98.53
Catoosa 15.77 24.11 19.65 11.85 2.41 28.10 7.25 $62,270 39 31,028 125.69
Charlton 12.79 60.83 8.99 20.58 8.98 51.02 12.02 $53,970 7 6847 102.23
Chatham 13.59 0.28 32.89 17.99 6.18 4.50 9.25 $61,810 153 127,704 119.81
Chattahoochee 3.85 46.88 30.12 14.30 7.45 29.52 15.96 $47,800 3 7039 42.62
Chattooga 16.16 49.64 8.86 22.40 3.08 57.56 10.06 $41,890 23 13,513 170.21
Cherokee 11.88 44.13 35.50 10.02 8.88 17.10 5.52 $84,420 89 105,874 84.06
Clarke 9.60 25.51 40.75 35.20 10.06 5.86 8.62 $51,160 54 55,388 97.49
Clay 23.89 25.22 7.44 39.81 2.64 100.00 18.94 $35,430 7 1462 478.80
Clayton 8.18 10.80 19.03 24.28 14.19 0.89 12.18 $47,260 130 124,232 104.64
Clinch 15.13 42.17 14.38 35.30 2.88 60.43 11.27 $37,070 10 3315 301.66
Cobb 10.58 31.16 44.99 11.64 15.68 0.25 6.78 $82,200 447 334,369 133.68
Coffee 12.57 25.63 13.08 24.50 5.87 66.58 7.27 $43,440 36 21,455 167.79
Colquitt 13.92 36.89 12.92 24.99 10.60 58.95 7.74 $39,510 22 22,576 97.45
Columbia 11.66 17.14 35.10 9.49 6.97 16.23 6.87 $79,820 66 60,328 109.40
Cook 14.71 33.46 13.84 26.23 2.61 59.41 5.37 $39,560 14 8372 167.22
Coweta 12.47 70.71 28.09 11.98 5.70 32.93 6.57 $74,710 81 62,242 130.14
Crawford 16.62 35.85 13.11 19.08 1.47 100.00 9.64 $48,160 8 6381 125.37
Crisp 15.45 36.08 15.08 32.93 2.65 47.03 13.93 $37,730 15 11,221 133.68
Dade 16.95 42.47 13.80 16.61 2.27 72.13 5.85 $56,020 12 8192 146.48
Dawson 18.19 9.72 29.84 13.42 3.42 80.31 7.47 $69,480 21 11,164 188.10
Decatur 10.33 29.67 41.74 18.99 16.28 56.48 9.76 $62,010 17 13,605 124.95
DeKalb 15.50 22.28 16.89 26.48 2.83 0.26 6.65 $45,580 410 331,355 123.73
Dodge 15.01 37.79 13.54 22.21 1.89 72.23 10.53 $46,660 13 11,449 113.55
Dooly 15.61 34.48 11.26 24.26 3.99 53.67 9.42 $45,240 7 8053 86.92
Dougherty 13.48 35.42 19.77 30.51 2.36 13.96 17.03 $39,890 87 43,927 198.06
Douglas 10.35 29.89 26.15 15.21 8.38 15.76 9.04 $65,010 67 63,772 105.06
Early 18.34 23.10 14.07 31.22 1.50 65.95 7.88 $36,070 10 5191 192.64
Echols 11.13 31.76 7.87 30.21 14.81 100.00 7.04 $50,860 3 2040 147.06
Effingham 10.59 59.60 18.28 10.84 2.71 67.05 5.99 $70,710 22 26,017 84.56
Elbert 18.88 42.31 11.69 19.75 2.24 70.62 8.29 $43,470 17 9656 176.06
Emanuel 15.63 63.49 11.71 29.49 0.98 66.88 11.55 $37,840 25 11,038 226.49
Evans 15.72 27.03 15.10 26.15 4.15 61.28 7.85 $48,520 7 5387 129.94
Fannin 25.49 35.35 17.72 18.00 1.87 100.00 9.23 $50,730 25 11,547 216.51
Fayette 16.04 39.31 45.78 7.14 9.23 18.18 6.35 $96,220 65 51,505 126.20
Floyd 15.50 16.50 19.80 19.75 6.77 36.82 9.28 $53,410 102 46,640 218.70
Forsyth 11.09 42.40 48.27 6.42 14.74 9.92 4.85 $103,920 114 87,194 130.74
Franklin 19.15 5.29 12.64 25.24 3.18 88.93 7.92 $46,800 11 10,911 100.82
Fulton 10.39 17.53 49.81 16.95 12.52 1.08 8.90 $80,420 593 448,267 132.29
Gilmer 21.64 16.52 17.84 19.45 6.91 87.64 7.75 $51,700 25 14,146 176.73
Glascock 16.90 23.58 8.22 15.19 0.66 100.00 6.85 $51,990 1 1487 67.25
Glynn 17.48 45.16 28.16 18.71 5.49 20.57 7.79 $56,320 58 37,855 153.22
Gordon 13.40 36.00 12.92 20.60 9.85 51.56 7.73 $45,890 30 27,283 109.96
Grady 16.28 32.73 12.77 29.62 5.69 62.36 9.18 $40,870 16 12,115 132.07
Greene 25.96 0.74 24.75 24.31 4.95 82.75 6.61 $54,440 22 7809 281.73
Gwinnett 8.59 36.48 34.93 13.02 24.72 0.49 6.85 $69,230 415 397,153 104.49
Habersham 17.70 62.20 17.51 18.33 8.80 58.76 7.22 $50,790 42 20,301 206.89
Hall 13.55 24.21 22.47 17.72 16.54 20.56 5.72 $60,460 134 89,601 149.55
Hancock 19.39 63.74 10.89 31.36 2.66 61.59 10.31 $30,910 11 5170 212.77
Haralson 15.82 32.82 13.76 20.28 1.39 77.36 10.29 $51,340 10 14,072 71.06
Harris 16.13 62.82 26.60 8.38 2.12 96.68 8.08 $81,000 29 15,975 181.53
Hart 20.38 46.10 13.65 21.22 2.60 74.47 5.59 $47,930 24 12,455 192.69
Heard 15.32 12.82 10.50 17.04 0.65 100.00 9.78 $54,820 8 5885 135.94
Henry 10.33 40.86 27.48 12.08 7.44 13.85 8.92 $69,640 103 97,859 105.25
Houston 11.80 58.90 24.03 17.95 5.53 9.96 8.80 $63,930 68 68,066 99.90
Irwin 17.70 20.66 11.15 24.89 0.56 64.71 6.92 $44,210 12 4804 249.79
Jackson 13.42 16.03 19.07 13.52 4.67 60.01 6.77 $62,980 45 30,002 149.99
Jasper 15.29 25.10 10.36 20.06 2.59 81.76 8.77 $45,140 6 6916 86.76
Jeff Davis . 38.94 8.35 . . 69.51 . . 19 7464 254.56
Jefferson 16.88 6.44 10.42 28.91 2.01 80.67 13.28 $41,100 12 8183 146.65
Jenkins 17.74 19.93 13.03 28.32 2.13 66.10 6.22 $41,910 6 3959 151.55
Johnson 15.48 52.27 8.69 25.17 0.68 65.41 9.27 $43,700 7 5592 125.18
Jones 15.77 31.51 20.23 13.69 1.03 67.71 8.05 $64,010 21 13,870 151.41
Lamar 15.95 18.24 17.16 22.17 2.31 60.87 13.04 $51,290 20 8852 225.94
Lanier 12.37 35.79 15.40 28.22 1.56 71.13 13.89 $44,600 9 5084 177.03
Laurens 16.30 36.51 15.24 27.75 2.17 56.64 5.94 $42,940 25 23,066 108.38
Lee 10.64 38.35 24.16 11.91 3.93 36.23 6.93 $72,360 19 14,097 134.78
Liberty 7.49 52.55 18.90 16.93 6.00 23.16 13.00 $46,500 13 30,962 41.99
Lincoln 20.51 0.76 13.15 25.36 1.40 100.00 9.06 $47,840 7 3896 179.67
Long 8.60 1.82 15.24 16.19 6.41 81.34 16.32 $54,780 7 7162 97.74
Lowndes 10.82 47.04 23.86 24.98 4.22 27.20 10.97 $50,800 48 53,285 90.08
Lumpkin 15.72 31.18 26.99 21.64 3.49 83.94 6.79 $51,680 27 14,894 181.28
Macon 14.39 11.11 8.53 32.56 2.59 53.19 16.93 $38,120 9 7973 112.88
Madison 15.88 17.56 15.47 16.10 3.84 91.88 8.01 $53,000 31 13,898 223.05
Marion 17.41 32.91 11.08 25.23 2.38 100.00 14.45 $44,250 12 4305 278.75
McDuffie 15.78 5.49 14.18 26.06 2.74 60.96 8.59 $45,190 18 10,250 175.61
McIntosh 20.12 57.78 13.77 20.13 2.09 74.31 9.93 $54,360 10 6989 143.08
Meriwether 18.40 12.50 10.15 23.71 0.60 83.28 11.18 $46,610 20 10,492 190.62
Miller 19.86 35.23 11.40 25.14 0.10 100.00 7.85 $47,530 11 2929 375.55
Mitchell 14.84 58.54 11.99 29.86 2.63 54.51 16.63 $37,780 27 12,186 221.57
Monroe 16.70 55.71 22.18 13.25 2.19 80.23 9.04 $60,030 13 13,271 97.96
Montgomery 15.54 58.77 15.55 22.82 5.42 98.71 5.77 $47,480 7 4695 149.09
Morgan 18.01 19.52 20.77 13.27 1.79 75.37 6.95 $58,750 18 8636 208.43
Murray 12.97 20.51 10.86 18.83 7.60 70.13 8.89 $46,560 28 19,652 142.48
Muscogee 12.00 12.96 25.00 20.91 5.51 2.98 10.05 $53,730 167 90,870 183.78
Newton 11.78 35.61 19.81 17.04 6.05 31.24 10.57 $57,230 79 47,626 165.88
Oconee 13.49 55.26 46.56 7.14 6.32 50.32 4.22 $85,780 22 16,007 137.44
Oglethorpe 17.30 34.38 16.62 17.91 2.33 99.25 5.61 $52,680 11 7385 148.95
Paulding 9.37 32.32 24.63 10.74 5.17 20.05 6.76 $69,820 73 69,578 104.92
Peach 13.07 25.00 20.15 21.02 5.34 38.22 10.45 $53,280 24 13,416 178.89
Pickens 20.28 59.26 24.76 10.27 2.99 73.10 7.20 $65,680 24 14,440 166.20
Pierce 15.54 31.91 12.90 19.94 2.45 79.35 8.30 $50,720 13 9202 141.27
Pike 14.51 57.78 15.31 12.13 0.91 98.96 10.01 $62,520 14 8742 160.15
Polk 14.88 26.79 12.98 20.14 7.05 51.42 8.73 $48,100 41 20,518 199.82
Pulaski 18.25 37.87 11.81 23.75 1.48 66.70 5.92 $46,830 8 5191 154.11
Putnam 21.31 44.37 18.29 17.76 5.72 80.95 8.03 $56,540 43 10,331 416.22
Quitman 25.49 14.91 8.56 25.68 1.62 73.10 18.53 $34,690 3 1200 250.00
Rabun 25.47 12.50 26.34 21.77 5.75 79.28 6.75 $53,470 18 8025 224.30
Randolph 18.29 56.68 13.35 28.66 2.39 50.63 9.75 $35,570 6 3552 168.92
Richmond 12.56 10.48 21.04 25.19 3.50 9.22 11.48 $46,840 137 97,015 141.22
Rockdale 12.57 5.95 25.96 17.16 9.61 14.93 10.26 $57,620 59 40,533 145.56
Schley 15.31 21.68 14.86 21.87 1.61 100.00 12.96 $47,760 2 2407 83.09
Screven 16.72 40.45 14.38 25.00 1.01 78.92 8.49 $42,460 10 7116 140.53
Seminole 21.30 45.34 14.92 19.08 1.38 68.55 8.74 $43,540 7 4139 169.12
Spalding 16.23 1.69 15.39 23.57 3.45 41.62 10.16 $50,060 63 31,046 202.92
Stephens 18.30 51.67 17.62 20.04 2.10 58.56 10.55 $50,870 19 12,528 151.66
Stewart 15.23 48.43 10.42 41.41 29.13 100.00 13.89 $22,500 3 3682 81.48
Sumter 14.88 22.67 19.95 33.62 3.13 41.78 12.70 $42,090 20 15,627 127.98
Talbot 19.61 20.36 12.65 20.69 0.97 93.88 9.31 $44,730 11 3245 338.98
Taliaferro 22.32 19.69 8.77 31.38 3.41 100.00 11.65 $41,630 2 841 237.81
Tattnall 12.16 0.00 11.37 27.68 3.58 68.24 5.07 $46,550 18 14,860 121.13
Taylor 18.02 61.97 11.32 28.39 1.22 100.00 17.91 $31,880 7 4301 162.75
Telfair 15.20 32.20 9.12 28.70 12.61 46.99 4.28 $30,470 13 9452 137.54
Terrell 17.56 32.26 12.08 34.72 0.59 51.00 12.13 $37,260 15 4479 334.90
Thomas 16.50 16.13 19.53 21.30 2.79 46.02 9.80 $46,330 32 21,179 151.09
Tift 13.67 41.55 17.52 27.48 6.42 40.78 5.09 $45,620 23 19,210 119.73
Toombs 14.99 26.02 17.02 26.56 6.16 51.06 10.83 $44,700 16 12,928 123.76
Towns 33.12 18.20 25.13 15.07 2.76 100.00 8.91 $48,720 19 4996 380.30
Treutlen 17.30 2.07 16.49 18.67 1.24 58.87 6.19 $55,410 3 3449 86.98
Troup 13.58 35.38 18.76 21.32 4.04 44.30 10.74 $52,120 52 32,215 161.42
Turner 18.35 42.67 12.28 27.65 4.31 49.73 9.13 $42,630 6 4358 137.68
Twiggs 19.53 69.23 11.64 30.32 1.08 100.00 7.74 $41,150 12 4398 272.85
Union 31.21 32.04 22.37 13.12 2.15 100.00 9.06 $53,700 26 10,397 250.07
Upson 17.56 38.54 13.35 22.94 1.34 46.91 12.47 $47,500 22 13,024 168.92
Walker 16.57 11.18 15.02 18.44 1.15 43.85 6.99 $51,320 43 33,781 127.29
Walton 14.17 2.97 18.58 13.20 3.86 42.66 7.81 $62,470 66 40,763 161.91
Ware 15.92 55.26 12.83 28.07 3.39 29.44 5.65 $42,150 32 18,069 177.10
Warren 20.48 2.69 12.09 26.38 1.98 100.00 12.54 $39,890 5 2694 185.60
Washington 15.88 46.51 12.30 26.40 1.67 65.60 10.70 $46,630 20 10,812 184.98
Wayne 14.51 32.56 13.32 20.58 2.82 57.94 12.83 $50,680 21 15,719 133.60
Webster 17.51 23.68 9.42 22.41 0.26 100.00 5.20 $51,370 4 1362 293.69
Wheeler 12.96 1.94 4.94 27.41 1.53 100.00 7.53 $36,210 5 4580 109.17
White 19.95 1.06 20.79 19.29 2.75 83.79 4.81 $50,120 18 13,269 135.65
Whitfield 12.71 28.43 13.55 19.63 18.31 29.08 9.63 $49,450 69 51,118 134.98
Wilcox 16.06 1.64 9.53 20.87 2.39 100.00 7.89 $45,350 7 5436 128.77
Wilkes 21.37 9.02 13.79 26.74 3.57 67.37 8.62 $47,480 10 5169 193.46
Wilkinson 17.77 34.09 8.64 20.79 0.77 100.00 7.38 $50,130 8 4582 174.60
Worth 16.90 47.81 10.21 18.44 1.65 69.16 8.23 $45,340 17 10,397 163.51

Risk factors from non-spatial and spatial models

Number of persons above age 65 years and below poverty, higher median family income, number of foreign born and unemployed were risk factors independently associated with prostate cancer risk in the non-spatial model (Fig. 1).

Fig. 1.

Fig. 1

Risk factors associated with prostate cancer incidence in the non-spatial model

Except for number of foreign born, all these significant risk factors in the non-spatial model were also significant in the spatial model with the same direction of effects (Fig. 2).

Fig. 2.

Fig. 2

Risk factors associated with prostate cancer incidence in the spatial model

Mapping predicted risk of prostate cancer incidence from the Bayesian spatial model

Substantial geographical variations in prostate cancer incidence were found in the study (Fig. 3). In addition, we presented the web-based interactive map of Fig. 3 in the supplementary material online. The predicted mean relative risk (RR) was 1.20 with a range of 0.53 (95% CI: 0.34, 0.78) to 2.92 (95% CI: 2.13, 3.86). Individuals residing in Towns, Clay, Union, Putnam, Quitman, and Greene counties were at increased risk of prostate cancer incidence while those residing in Chattahoochee were at the lowest risk of prostate cancer incidence.

Fig. 3.

Fig. 3

Spatial distribution of predicted prostate cancer relative risk in the Georgia State. Source: This map was produced by the authors

Presented in Figs. 4 and 5 are the predictive maps of the probability that the relative risk will exceed 1.5 and 2 respectively at a given county in the Georgia State. We also presented the web-based interactive map of Figs. 4 and 5 in the supplementary material online. The deep red regions represent counties where the probability of the relative risk exceeding 1.5 (Fig. 4) and 2 (Fig. 5) are high.

Fig. 4.

Fig. 4

Predictive maps for exceedance probability of relative risk of 1.5 (i.e. P (RR > 1.5)). Source: This map was produced by the authors

Fig. 5.

Fig. 5

Predictive maps for exceedance probability of relative risk of 2 (i.e. P (RR > 2)). Source: This map was produced by the authors

The probability that the relative risk will exceed 1.5 is highest in Union, Towns, Putnam, Greene and Quitman counties (Fig. 4). Also, the probability that the relative risk will exceed 2 is highest in Towns county with a probability of 0.99 (Fig. 5).

Discussion

The study sets out to use Bayesian geospatial methods to model and map prostate cancer incidence in Georgia counties, and to evaluate county sociodemographic factors associated with high incidence of prostate cancer for the purpose of optimal planning for prostate cancer interventions amidst limited public health resources. Critical risk factors for prostate cancer identified in the present study included number of persons above 65 years of age and below poverty, median family income and number of foreign born and the unemployed in counties. In contrast to previous studies [5, 7], our study did not find an association between prostate cancer incidence and proportions of blacks and rural population.

One of the important aims of this study is identification of high-risk counties for public health interventions amidst limited public health resources. This is critical because residential location of people could act as a marker for the socioeconomic, personal, and climatic/environmental factors that influence access to healthcare services and the general health of the people. Thus, spatial modelling and mapping provides the required tools to obtain an improved understanding of health outcomes of people by place for targeted public health interventions [7, 2327]. The predicted relative risk ranges from 0.53 (95% CI: 0.34, 0.78) in Chattahoochee to 2.92 (95% CI: 2.13, 3.86) in Towns with a mean of 1.20. The study identified Towns (2.92) as the county with the highest prostate cancer incidence. Other counties with relatively high incidence include Clay (RR = 2.55), Quitman (RR = 2.39), Union (RR = 2.30), Greene (RR = 2.14) and Putnam (RR = 2.13) counties were at increased risk of prostate cancer incidence.

On closer examination of high risk prostate cancer counties, we observed that despite being predominantly white and better educated (25.1% with a Bachelor’s degree) the main driver of risk in Towns County in the north of Georgia was its older population, reporting the largest proportion of persons at least 65 years of age (33.1%). While advancing age is a well-known risk factor for prostate cancer, Clay and Quitman Counties in also suggest that low educational attainment (7.4 and 8.5% with a Bachelor’s degree), high unemployment (18.9 and 18.5%) and individual poverty (39.8 and 25.6%) may be additional risk factors in black communities. Exactly how these socioeconomic indices may impact prostate cancer risk within older black populations is not well known, but high cigarette use and alcohol consumption as well as poor diet have been hypothesized to mediate or moderate this risk [28]. Furthermore, risk factors of exposures to water, air and soil pollution from agricultural farming of cash crops such as cotton, from the southwest through to central Georgia, may also be involved [29]. As neighbouring lower risk counties with large or predominantly black populations likely shared these environmental conditions with Clay and Quitman, our modelling suggests that prostate cancer risk in both communities is multifactorial, resulting from a possible confluence of negative lifestyle, economic and environmental factors experienced over long periods of time.

In comparing the high-risk counties with Chattahoochee and rural low-risk counties, we observed that population age was the single most obvious distinction. Low risk counties had a smaller proportion of elderly persons, irrespective of whether they were classified as rural, and in particular, Chattahoochee had the youngest population (3.8% 65 years and older) with the highest educational attainment (30% with a Bachelor’s degree).

Our study supports the findings of others that reported geographical differences in health outcomes such as prostate and lung cancers, malaria, malnutrition, mortality among others [5, 7, 2325, 30]. Against the backdrop of a national reduction in incident prostate cancer, there remain pockets of high risk in the north, southwest as well as central areas of Georgia. The present study suggests that there may be racial differences in prostate cancer risk within counties. The aging population may be the main risk factor in overwhelmingly white counties while limited education and poverty may play a larger role in black counties. It should be noted that although several counties with large African American populations were observed to have a high-risk of prostate cancer incidence, the present study found no association between race and prostate cancer risk, in part because these counties tended to be considerably smaller than predominantly white counties. Importantly, this is an ecological study and the associations discussed herein should not be regarded as causal or necessarily significant at the level of individual prostate cancer patients. Prostate Specific Antigen (PSA) screening has driven prostate cancer diagnosis since the 1980s [31, 32]. However, this reliance on PSA has come at the cost of overtreatment and its complications among many low risk men, and in May 2012, the US Prevention Services Task Force (USPSTF) recommended against routine PSA screening for all men [32, 33]. While current diagnostic practices among prostate cancer patients may be of interest and the scope of the present study may represent a substantial post-recommendation period, our study design additionally prevents comparisons that are better made over time among individual patients managed by primary care physicians [32]. Furthermore, we did not include individual-level diagnostic data in our analysis. With these constraints in mind, our results are best suited for hypotheses generation.

Strengths and limitation

The use of Bayesian spatial analysis methods in this study provided an essential tool for the investigation of prostate cancer incidence in relation to risk factors to help in the better understanding of spatial distribution and potential etiologic mechanism of prostate cancer disease using an internationally recognised gold standard SEER data. Our modelling approach also allowed counties with small counts to borrow information from their neighbouring counties thereby reducing the risk of inflated relative risk due to small expected counts. Furthermore, unlike the frequentist spatial modelling approach, our Bayesian spatial modelling approach allowed graphical presentation of the posterior distribution of risk factor effects on the prostate cancer incidence as presented in Figs. 1 and 2. The present study might have left out some potential risk factors that might explain some of the geographical differences in prostate cancer disease observed in the study so the findings should be interpreted with caution.

Our findings broadly support previous studies [2, 1517, 34] that report that older ages (≥65 years), income (number below poverty and median family income), race (being a foreign born) and unemployed are critical risk factors for prostate cancer disease. For example, the finding that the number of persons aged 65 years or older increased the risk of the disease supports previous studies that reported that prostate cancer risk increases with age, and with incidence rate over 60% [3436]. The finding that increased number of foreign born increases the risk of prostate cancer disease supports previous studies that reported prostate cancer inequality by race [7].

Conclusion

Our modelling approach captured variation in prostate cancer risk over the whole of the Georgia State. The risk maps indicate substantial geographical variations in the risk of prostate cancer. This can be used as an effective tool in the identification of counties that require targeted interventions and further research by program managers and implementers as part of an overall strategy in reducing the prostate cancer burden in the Georgia State and the U.S. as a whole. For example, a further research could aim at identifying as yet unidentified risk factors that might have accounted for the geographical differences we observed in the prostate cancer disease among the counties in the Georgia State after we have accounted for the present risk factors in our model.

Furthermore, we advocate for implementation of focused strategies to decrease prostate cancer incidence and to improve survival in the presence of the identified critical risk factors in this study.

Supplementary Information

Additional file 1. (862.6KB, html)
Additional file 2. (852.9KB, html)
Additional file 3. (852.4KB, html)

Acknowledgements

This Fellowship was supported by the University of Ghana Building a New Generation of Academics in Africa (BANGA-Africa) Project with funding from the Carnegie Corporation of New York. The statements made and views are solely the responsibility of the authors. We are also grateful to the Surveillance, Epidemiology, and End Results (SEER) Program for making the data available for the study.

Abbreviations

AA

African American

CI

Credible Interval

ICD-O-3

International Classification of Diseases for Oncology, third edition

INLA

Integrated Nested Laplace Approximation

RR

Relative Risk

SEER

Surveillance, Epidemiology, and End Results

SPDE

Stochastic Partial Differential Equation

U.S.

United States of America

Authors’ contributions

JMKA developed the concept. JMKA and OAU secured the data. JMKA analysed the data and wrote the first draft manuscript. JMKA, OAU and GAD contributed to the writing and reviewing of the various sections of the manuscript. All the authors reviewed the final version of the manuscript before submission. All authors read and approved the final manuscript.

Funding

Funding is not applicable to this paper. As a corresponding author, I have full access to all the data in the study and had final responsibility for the decision to submit for publication.

Availability of data and materials

Data is freely available upon making official request to Surveillance, Epidemiology, and End Results (SEER) Program through the website at https://seer.cancer.gov/.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Roehrborn CG, Black LK. The economic burden of prostate cancer. BJU Int. 2011;108(6):806–813. doi: 10.1111/j.1464-410X.2011.10365.x. [DOI] [PubMed] [Google Scholar]
  • 2.Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi: 10.3322/caac.21551. [DOI] [PubMed] [Google Scholar]
  • 3.CDC:Centers for Disease Control and Prevention . United States Cancer Statistics. CDC; 2019. [Google Scholar]
  • 4.Kelly SP, Rosenberg PS, Anderson WF, Andreotti G, Younes N, Cleary SD, Cook MB. Trends in the incidence of fatal prostate Cancer in the United States by race. Eur Urol. 2017;71(2):195–201. doi: 10.1016/j.eururo.2016.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wagner SE, Hurley DM, Hébert JR, McNamara C, Bayakly AR, Vena JE. Cancer mortality-to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants. Cancer. 2012;118(16):4032–4045. doi: 10.1002/cncr.26728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.USCB: United States Census Bureau . State and County Quick Facts: Georgia. USCB; 2020. [Google Scholar]
  • 7.Wagner SE, Bauer SE, Bayakly AR, Vena JE. Prostate cancer incidence and tumor severity in Georgia: descriptive epidemiology, racial disparity, and geographic trends. Cancer Causes Control. 2013;24(1):153–166. doi: 10.1007/s10552-012-0101-0. [DOI] [PubMed] [Google Scholar]
  • 8.McNamara C, Davis V, Bayakly AR, Moon T. Prostate Cancer in Georgia, 2002-2006. Georgia Department of Community Health, Division of Public Health, Chronic Disease, Healthy Behaviors, and Injury Epidemiology; 2010. [Google Scholar]
  • 9.SEER: Surveillance Epidemiology and End Results Program . Georgia Center for Cancer Statistics. SEER; 2020. [Google Scholar]
  • 10.Ruhl J, Adamo M, Dickie L. SEER Program Coding and Staging Manual 2016: Section V. Bethesda: National Cancer Institute; 2016. [Google Scholar]
  • 11.Scosyrev E, Messing J, Noyes K, Veazie P, Messing E. Surveillance epidemiology and end results (SEER) program and population-based research in urologic oncology: an overview. Urol Oncol. 2012;30(2):126–132. doi: 10.1016/j.urolonc.2009.11.005. [DOI] [PubMed] [Google Scholar]
  • 12.Duggan MA, Anderson WF, Altekruse S, Penberthy L, Sherman ME. The surveillance, epidemiology, and end results (SEER) program and pathology: toward strengthening the critical relationship. Am J Surg Pathol. 2016;40(12):e94–e102. doi: 10.1097/PAS.0000000000000749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Overview of the surveillance, epidemiology, and end results database: evolution, data variables, and quality assurance. Curr Probl Cancer. 2012;36(4):183–190. doi: 10.1016/j.currproblcancer.2012.03.007. [DOI] [PubMed] [Google Scholar]
  • 14.Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer. 1995;76(11):2343–2350. doi: 10.1002/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  • 15.ACS: American Cancer Society . Cancer Statistics Center: Georgia. ACS; 2019. [Google Scholar]
  • 16.Lund Nilsen TI, Johnsen R, Vatten LJ. Socio-economic and lifestyle factors associated with the risk of prostate cancer. Br J Cancer. 2000;82(7):1358–1363. doi: 10.1054/bjoc.1999.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hastert TA, Beresford SA, Sheppard L, White E. Disparities in cancer incidence and mortality by area-level socioeconomic status: a multilevel analysis. J Epidemiol Community Health. 2015;69(2):168–176. doi: 10.1136/jech-2014-204417. [DOI] [PubMed] [Google Scholar]
  • 18.Besag J, York J, Mollié A. Bayesian image restoration with applications in spatial statistics (with discussion) Ann Inst Stat Math. 1991;43(1):1–59. doi: 10.1007/BF00116466. [DOI] [Google Scholar]
  • 19.Lindgren F, Rue H, Lindström J. An explicit link between Gaussian fields and Gaussian Markov random fields: the stochastic partial differential equation approach. J R Stat Soc B Stat Meth. 2011;73(4):423–498. doi: 10.1111/j.1467-9868.2011.00777.x. [DOI] [Google Scholar]
  • 20.Rue H, Martino S, Chopin N. Approximate Bayesian inference for latent Gaussian models by using integrated nested Laplace approximations. J R Stat Soc B Stat Meth. 2009;71:319–92.
  • 21.Lindgren F, Rue H. Bayesian Spatial Modelling with R-INLA. J Stat Softw. 2015;1(19):2015. [Google Scholar]
  • 22.Rue H, Martino S, Lindgren F, Simpson D, Riebler A, Krainski E. R package version 00-1404466487. 2014. INLA: Functions Which Allow to Perform a Full Bayesian Analysis of Structured Additive Models Using Integrated Nested Laplace Approximaxion. [Google Scholar]
  • 23.Aheto JMK, Taylor BM, Keegan TJ, Diggle PJ. Modelling and forecasting spatio-temporal variation in the risk of chronic malnutrition among under-five children in Ghana. Spat Spatiotemporal Epidemiol. 2017;21:37–46. doi: 10.1016/j.sste.2017.02.003. [DOI] [PubMed] [Google Scholar]
  • 24.Aheto JMK. Predictive model and determinants of under-five child mortality: evidence from the 2014 Ghana demographic and health survey. BMC Public Health. 2019;19(1):64. doi: 10.1186/s12889-019-6390-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Diggle P, Moyeed R, Rowlingson B, Thomson M. Childhood malaria in the Gambia: A case-study in model-based geostatistics. J R Stat Soc C Appl Stat. 2002;51:493–506. doi: 10.1111/1467-9876.00283. [DOI] [Google Scholar]
  • 26.Kandala NB, Madungu TP, Emina JB, Nzita KP, Cappuccio FP. Malnutrition among children under the age of five in the Democratic Republic of Congo (DRC): does geographic location matter? BMC Public Health. 2011;11(1):261. doi: 10.1186/1471-2458-11-261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nykiforuk CI, Flaman LM. Geographic information systems (GIS) for health promotion and public health: a review. Health Promot Pract. 2011;12(1):63–73. doi: 10.1177/1524839909334624. [DOI] [PubMed] [Google Scholar]
  • 28.Brotherton L, Welton M, Robb SW. Racial disparities of pancreatic cancer in Georgia: a county-wide comparison of incidence and mortality across the state, 2000-2011. Cancer Med. 2016;5(1):100–110. doi: 10.1002/cam4.552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Blomme C, Roubal A, Givens M, Johnson S, Brown L. Georgia County Health Rankings State Report 2020. University of Wisconsin Population Health Institute; 2020. [Google Scholar]
  • 30.Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, Charara R, Allen C, Naghavi M, Murray CJL. Trends and patterns of disparities in Cancer mortality among US counties, 1980-2014. JAMA. 2017;317(4):388–406. doi: 10.1001/jama.2016.20324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324(17):1156–1161. doi: 10.1056/NEJM199104253241702. [DOI] [PubMed] [Google Scholar]
  • 32.Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation. Urol Oncol. 2014;32(1):41.e23–41.e30. doi: 10.1016/j.urolonc.2013.04.013. [DOI] [PubMed] [Google Scholar]
  • 33.Jemal A, Fedewa SA, Ma J, Siegel R, Lin CC, Brawley O, Ward EM. Prostate Cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA. 2015;314(19):2054–2061. doi: 10.1001/jama.2015.14905. [DOI] [PubMed] [Google Scholar]
  • 34.Gann PH. Risk factors for prostate cancer. Rev Urol. 2002;4 Suppl 5(Suppl 5):S3–S10. [PMC free article] [PubMed] [Google Scholar]
  • 35.Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10(2):63–89. doi: 10.14740/wjon1191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Merriel SWD, Funston G, Hamilton W. Prostate Cancer in primary care. Adv Ther. 2018;35(9):1285–1294. doi: 10.1007/s12325-018-0766-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1. (862.6KB, html)
Additional file 2. (852.9KB, html)
Additional file 3. (852.4KB, html)

Data Availability Statement

Data is freely available upon making official request to Surveillance, Epidemiology, and End Results (SEER) Program through the website at https://seer.cancer.gov/.


Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES